Prelude Capital Management, LLC Aerie Pharmaceuticals Inc Transaction History

Prelude Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $528,735 - $1.26 Million	83,004 New	83,004 $1.26 Million
Q3 2020 Nov 16, 2020	SELL	$10.46 - $14.46 $154,661 - $213,805	-14,786 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $46,560 - $62,584	3,880 Added 35.58%	14,786 $218,000
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $107,021 - $230,675	-9,039 Reduced 45.32%	10,906 $147,000
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $353,425 - $500,619	19,945 New	19,945 $482,000
Q3 2019 Nov 14, 2019	SELL	$18.41 - $28.0 $4,344 - $6,608	-236 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$28.97 - $48.21 $769,935 - $1.28 Million	-26,577 Reduced 99.12%	236 $7,000
Q1 2019 May 15, 2019	BUY	$36.32 - $49.25 $459,847 - $623,554	12,661 Added 89.46%	26,813 $1.27 Million
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $624,360 - $1.14 Million	-18,920 Reduced 57.21%	14,152 $511,000
Q3 2018 Nov 14, 2018	SELL	$56.15 - $73.9 $350,712 - $461,579	-6,246 Reduced 15.89%	33,072 $2.04 Million
Q2 2018 Aug 14, 2018	SELL	$47.85 - $70.45 $843,260 - $1.24 Million	-17,623 Reduced 30.95%	39,318 $2.66 Million
Q1 2018 May 15, 2018	BUY	$51.15 - $61.0 $1.28 Million - $1.52 Million	24,974 Added 78.12%	56,941 $3.09 Million
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $727,460 - $931,320	14,306 Added 81.0%	31,967 $1.91 Million
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $858,324 - $1.06 Million	17,661	17,661 $858,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.